A BRCA2-mutant, HR-deficient serous ovarian cancer model used as a therapy-sensitive comparator for DNA repair, platinum sensitivity and PARP inhibitor sensitivity studies. Only available from CancerTools.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.